These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 1868512

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Pulmonary manifestations of hepatic diseases].
    Cereda JM.
    Rev Med Suisse Romande; 1993 Dec; 113(12):1025-8. PubMed ID: 8290844
    [No Abstract] [Full Text] [Related]

  • 26. Management of secondary hyperlipemia by pancreatic extract.
    Chu YC, Oliver HT, Doyle WM.
    N Y State J Med; 1967 Jun 15; 67(12):1780-4. PubMed ID: 5232557
    [No Abstract] [Full Text] [Related]

  • 27. [Cystic fibrosis: current therapy. Pancreatic enzyme supplementation].
    Schibli S.
    Schweiz Med Wochenschr Suppl; 2000 Jun 15; 122():12S-14S. PubMed ID: 12536463
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Secondary gastroduodenal ulcers and erosions in patients with chronic liver and pancreatic diseases].
    Geller LI, Mamontova MI, Bulgakova OS.
    Vrach Delo; 1984 Oct 15; (10):32-5. PubMed ID: 6516304
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Use of the Romanian product Silimarina in the treatment of chronic liver diseases.
    Tănăsescu C, Petrea S, Băldescu R, Macarie E, Chiriloiu C, Purice S.
    Med Interne; 1988 Oct 15; 26(4):311-22. PubMed ID: 3072661
    [Abstract] [Full Text] [Related]

  • 35. Ultrasonographic and tomographic evaluation of the chronic liver diseases.
    Cichoz-Lach H, Drop A, Jezierska E, Celiński K, Słomka M, Daniluk J Pokora J, Pokora J.
    Ann Univ Mariae Curie Sklodowska Med; 1995 Oct 15; 50():77-82. PubMed ID: 9263493
    [No Abstract] [Full Text] [Related]

  • 36. Sleep disorders in chronic liver disease.
    De Cruz S, Espiritu JR, Zeidler M, Wang TS.
    Semin Respir Crit Care Med; 2012 Feb 15; 33(1):26-35. PubMed ID: 22447258
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Fibrinolysis as a cause of coagulopathy in patients with chronic diffuse diseases of the liver].
    Serov NA, Sukhanov VA, Podymova SD.
    Klin Med (Mosk); 1991 Apr 15; 69(4):73-5. PubMed ID: 1865658
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Significance of thymidine phosphorylase in HCC with chronic liver disease for long-term postoperative recurrence.
    Ezaki T, Ikegami T, Ishida T, Aimitsu S, Mori M, Fujihara M.
    J Surg Oncol; 2003 Jul 15; 83(3):173-9; discussion 179. PubMed ID: 12827687
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.